Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas

被引：0
|
作者：
Carsten Zwick
Gerhard Held
Vera Hammermeister
Adnan AlAhmad
Boris Kubuschok
Joerg Bittenbring
Manfred Ahlgrimm
Frank Neumann
Klaus-Dieter Preuss
Michael Pfreundschuh
机构：
[1] Saarland University Medical School Homburg,Innere Medizin I, Jose
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Aggressive lymphomas; BCL-2; Immunogenicity; Antibody response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1207 / 1213
页数：6
相关论文
共 50 条
  • [21] BCL-2 system analysis identifies high-risk colorectal cancer patients
    Lindner, Andreas U.
    Salvucci, Manuela
    Morgan, Clare
    Monsefi, Naser
    Resler, Alexa J.
    Cremona, Mattia
    Curry, Sarah
    Toomey, Sinead
    O'Byrne, Robert
    Bacon, Orna
    Stuhler, Michael
    Flanagan, Lorna
    Wilson, Richard
    Johnston, Patrick G.
    Salto-Tellez, Manuel
    Camilleri-Broet, Sophie
    McNamara, Deborah A.
    Kay, Elaine W.
    Hennessy, Bryan T.
    Laurent-Puig, Pierre
    Van Schaeybroeck, Sandra
    Prehn, Jochen H. M.
    GUT, 2017, 66 (12) : 2141 - 2148
  • [22] High levels of bcl-2 protein in the T lymphocytes of patients with Behcet's disease
    Hamzaoui, A
    Hamzaoui, K
    Kooli, C
    Chabbou, A
    Hentati, F
    Ayed, K
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (01) : 106 - 107
  • [23] Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients
    Zoernig, Inka
    Halama, Niels
    Bermejo, Justo Lorenzo
    Ziegelmeier, Claudia
    Dickes, Elke
    Migdoll, Alexander
    Kaiser, Iris
    Waterboer, Tim
    Pawlita, Michael
    Grabe, Niels
    Ugurel, Selma
    Schadendorf, Dirk
    Falk, Christine
    Eichmueller, Stefan B.
    Jaeger, Dirk
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (01) : 138 - 151
  • [24] Bcl-2, Bcl-X, Pax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas
    Bairey, O
    Zimra, Y
    Shaklai, M
    Okon, E
    Rabizadeh, E
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 2860 - 2866
  • [25] Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection
    Libra, M
    De Re, V
    Gloghini, A
    Gasparotto, D
    Gragnani, L
    Navolanic, PM
    De Vita, S
    Mazzarino, MC
    Zignego, AL
    Carbone, A
    Boiocchi, M
    HAEMATOLOGICA, 2004, 89 (07) : 873 - 874
  • [26] ANTIBODY-RESPONSES IN LYME BORRELIOSIS - IGG2 DIRECTED AGAINST SPIROCHETAL SURFACE CARBOHYDRATE MOIETIES
    KOHLI, M
    SCHULTZ, J
    LUFT, BJ
    VOLKMAN, DJ
    CLINICAL RESEARCH, 1989, 37 (03): : A856 - A856
  • [27] Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients
    Patil, Harshad P.
    Rane, Prajakta S.
    Shrivastava, Shubham
    Palkar, Sonali
    Lalwani, Sanjay
    Mishra, Akhilesh C.
    Arankalle, Vidya A.
    VIRAL IMMUNOLOGY, 2021, 34 (03) : 201 - 209
  • [28] VENETOCLAX IS A PROMISING DRUG FOR THE FUTURE PERSONALIZED TREATMENT OF NEUROBLASTOMA PATIENTS WITH HIGH BCL-2 EXPRESSION
    Bate-Eya, L.
    Van der Ploeg, I.
    den Hartog, I.
    Schild, L.
    Koster, J.
    Versteeg, R.
    Caron, H.
    Molenaar, J.
    Dolman, E.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S327 - S327
  • [29] P53 AND BCL-2 EXPRESSION IN HIGH-GRADE B-CELL LYMPHOMAS - CORRELATION WITH SURVIVAL-TIME
    PIRIS, MA
    PEZELLA, F
    MARTINEZMONTERO, JC
    ORRADRE, JL
    VILLUENDAS, R
    SANCHEZBEATO, M
    CUENA, R
    CRUZ, MA
    MARTINEZ, B
    GARRIDO, MC
    GATTER, K
    AIELLO, A
    DELIA, D
    GIARDINI, R
    RILKE, F
    BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 337 - 341
  • [30] EXPRESSION OF CD95 AND BCL-2 PROTEINS IN LOW-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    NGUYEN, PL
    ROBERTSON, MJ
    RITZ, J
    HARRIS, NL
    LABORATORY INVESTIGATION, 1995, 72 (01) : A118 - A118
12345